![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
1 Am J Clin Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive
and HER2-low Metastatic Breast Cancer: A Single-center Experience and Review of
the Literature.
Am J Clin Oncol. 2024 Jul 16. doi: 10.1097/COC.0000000000001135.
PubMed
Abstract available
Studying the association Between longitudinal non-dense breast tissue and breast
cancer risk: a joint modelling approach.
Am J Epidemiol. 2024 Jul 11:kwae196. doi: 10.1093.
PubMed
Abstract available
Surgical Perspectives on the Updated ASTRO Guideline on Partial Breast
Irradiation for Breast Cancer.
Ann Surg Oncol. 2024 Jul 13. doi: 10.1245/s10434-024-15639.
PubMed
Abstract available
Longitudinal Increases in Time to Surgery for Patients with Breast Cancer: A
National Cohort Study.
Ann Surg Oncol. 2024 Jul 13. doi: 10.1245/s10434-024-15723.
PubMed
Abstract available
Implementation of Choosing Wisely((R)) Recommendations for Lymph Node Surgery in
Male Breast Cancer.
Ann Surg Oncol. 2024 Jul 20. doi: 10.1245/s10434-024-15811.
PubMed
Abstract available
ASO Visual Abstract: Persistent Pain After Breast Cancer
Treatment, an Underreported Burden for Breast Cancer Survivors.
Ann Surg Oncol. 2024 Jul 18. doi: 10.1245/s10434-024-15850.
PubMed
ASO Author Reflections: Management of Inflammatory Breast Cancer: No Role for
Surgical De-escalation Yet.
Ann Surg Oncol. 2024 Jul 17. doi: 10.1245/s10434-024-15806.
PubMed
ASO Author Reflections: Trajectory of Subsequent Breast Cancer After Breast
Atypia Diagnosis Suggests Need for Vigilant Follow-up.
Ann Surg Oncol. 2024 Jul 17. doi: 10.1245/s10434-024-15869.
PubMed
ASO Visual Abstract: Validation of the AJCC Eighth-Edition Breast Cancer
Prognostic Staging System in Legacy Alliance Trials (AFT-01).
Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15620.
PubMed
Utility of Axillary Staging in Older Patients with HER2-Positive Breast Cancer.
Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15812.
PubMed
Abstract available
Disparities in the Occurrence of Long-Term Effects of Bone Marrow Suppression
after Treatment in Adolescent Young Adult Breast Cancer Survivors.
Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15707.
PubMed
Abstract available
ASO Visual Abstract: Residual Axillary Metastases in Node-Positive Breast Cancer
Patients After Neoadjuvant Treatment-A Register-Based Study.
Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15752.
PubMed
ASO Visual Abstract: Guideline-Concordant Surgical Care for Lobular Versus Ductal
Inflammatory Breast Cancer.
Ann Surg Oncol. 2024 Jul 15. doi: 10.1245/s10434-024-15691.
PubMed
ASO Visual Abstract: Axillary Reverse Mapping Aids in Reducing the Rates of
Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population.
Ann Surg Oncol. 2024 Jul 15. doi: 10.1245/s10434-024-15832.
PubMed
A protocol for a multidisciplinary early intervention during chemotherapy to
improve dietary management behavior in breast cancer patients: a two-arm,
single-center randomized controlled trial.
BMC Cancer. 2024;24:859.
PubMed
Abstract available
Investigating the effects of artificial intelligence on the personalization of
breast cancer management: a systematic study.
BMC Cancer. 2024;24:852.
PubMed
Abstract available
Risk factors for residual fibroglandular breast tissue following a mastectomy -
an overview and retrospective cohort study.
BMC Cancer. 2024;24:856.
PubMed
Abstract available
Effect of PR status on the prognosis of advanced ER-high HER2-negative breast
cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line
therapy.
BMC Cancer. 2024;24:850.
PubMed
Abstract available
Breast cancer preventive practices and associated factors among reproductive age
women in Wadila District, North East Ethiopia: community based cross-sectional
study.
BMC Cancer. 2024;24:843.
PubMed
Abstract available
Does axillary lymph node recurrence breast cancer subtype information matter for
prognosis estimation?
Breast Cancer. 2024 Jul 20. doi: 10.1007/s12282-024-01620.
PubMed
Identification and validation of screening models for breast cancer with 3 serum
miRNAs in an 11,349 samples mixed cohort.
Breast Cancer. 2024 Jul 19. doi: 10.1007/s12282-024-01619.
PubMed
Abstract available
Development of a nomogram to predict recurrence scores obtained using Oncotype DX
in Japanese patients with breast cancer.
Breast Cancer. 2024 Jul 17. doi: 10.1007/s12282-024-01616.
PubMed
Abstract available
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer
with TP53 pathogenic variant carriers.
Breast Cancer. 2024 Jul 17. doi: 10.1007/s12282-024-01612.
PubMed
Abstract available
Breast Cancer (Dove Med Press)
Role of AURKB Inhibition in Reducing Proliferation and Enhancing Effects of
Radiotherapy in Triple-Negative Breast Cancer.
Breast Cancer (Dove Med Press). 2024;16:341-346.
PubMed
Abstract available
Associations between quantitative measures of mammographic density and terminal
ductal lobular unit involution in Chinese breast cancer patients.
Breast Cancer Res. 2024;26:116.
PubMed
Abstract available
Peripheral blood immune parameters, response, and adverse events after
neoadjuvant chemotherapy plus durvalumab in early-stage triple-negative breast
cancer.
Breast Cancer Res Treat. 2024 Jul 13. doi: 10.1007/s10549-024-07426.
PubMed
Abstract available
Correction: Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in
HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and
predictive value for endocrine therapy resistance in real-world practice.
Breast Cancer Res Treat. 2024 Jul 13. doi: 10.1007/s10549-024-07427.
PubMed
Feasibility and preliminary effects of the Fit2ThriveMB pilot physical activity
promotion intervention on physical activity and patient reported outcomes in
individuals with metastatic breast cancer.
Breast Cancer Res Treat. 2024 Jul 16. doi: 10.1007/s10549-024-07432.
PubMed
Abstract available
CD133 expression is associated with less DNA repair, better response to
chemotherapy and survival in ER-positive/HER2-negative breast cancer.
Breast Cancer Res Treat. 2024 Jul 17. doi: 10.1007/s10549-024-07434.
PubMed
Abstract available
Genomic and transcriptomic profiling of inflammatory breast cancer reveals
distinct molecular characteristics to non-inflammatory breast cancers.
Breast Cancer Res Treat. 2024 Jul 19. doi: 10.1007/s10549-024-07437.
PubMed
Abstract available
Breast cancer risk reduction: Beyond pharmacologic intervention.
Cancer. 2024 Jun 21. doi: 10.1002/cncr.35442.
PubMed
Lenvatinib plus pembrolizumab for patients with previously treated, advanced,
triple-negative breast cancer: Results from the triple-negative breast cancer
cohort of the phase 2 LEAP-005 Study.
Cancer. 2024 Jun 21. doi: 10.1002/cncr.35387.
PubMed
Abstract available
Inequities in breast cancer from prevention through supportive care.
Cancer. 2024;130:2570.
PubMed
Impact of ALDH1A1 and NQO1 gene polymorphisms on the response and toxicity of
chemotherapy in Bangladeshi breast cancer patients.
Cancer Chemother Pharmacol. 2024 Jul 16. doi: 10.1007/s00280-024-04700.
PubMed
Abstract available
UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in
Giredestrant Exposure.
Cancer Chemother Pharmacol. 2024;94:117-122.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
Systematic review and meta-analysis of lifestyle and reproductive factors
associated with risk of breast cancer in Asian women.
Cancer Epidemiol Biomarkers Prev. 2024.
PubMed
Abstract available
Socio-demographic disparities in HER2+ breast cancer trastuzumab receipt: An
English population-based study.
Cancer Epidemiol Biomarkers Prev. 2024.
PubMed
Abstract available
Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in
Triple-Negative Breast Cancer.
Cancer Res. 2024 Jul 18. doi: 10.1158/0008-5472.CAN-24-0970.
PubMed
Abstract available
Development of a Preoperative Prediction Model Based on Spectral CT to Evaluate
Axillary Lymph Node With Macrometastases in Clinical T1/2N0 Invasive Breast
Cancer.
Clin Breast Cancer. 2024 Jun 18:S1526-8209(24)00174.
PubMed
Abstract available
Antiapoptotic and Prometastatic Roles of Cytokine FAM3B in Triple-Negative Breast
Cancer.
Clin Breast Cancer. 2024 Jun 22:S1526-8209(24)00173.
PubMed
Abstract available
Integration of Radiomics and Immune-Related Genes Signatures for Predicting
Axillary Lymph Node Metastasis in Breast Cancer.
Clin Breast Cancer. 2024 Jun 25:S1526-8209(24)00179.
PubMed
Abstract available
Associations of immune checkpoint predictive biomarkers MHC-I and MHC-II with
clinical and molecular features in a diverse breast cancer cohort.
Clin Cancer Res. 2024 Jul 15. doi: 10.1158/1078-0432.CCR-24-1286.
PubMed
Abstract available
Response to letter re: Ki-67 index after neoadjuvant endocrine therapy as a
prognostic biomarker in patients with ER-positive/HER2-negative early breast
cancer: a systematic review and meta-analysis.
Eur J Cancer. 2024;208:114195.
PubMed
Recurrence and associated factors of breast cancer among women in sub saharan
africa, systematic review and meta-analysis.
Eur J Surg Oncol. 2024;50:108528.
PubMed
Abstract available
Diagnostic performance of 3D automated breast ultrasound (3D-ABUS) in a clinical
screening setting-a retrospective study.
Eur Radiol. 2024;34:5451-5460.
PubMed
Abstract available
Current use and future perspectives of contrast-enhanced mammography (CEM): a
survey by the European Society of Breast Imaging (EUSOBI).
Eur Radiol. 2024;34:5439-5450.
PubMed
Abstract available
Interval cancer in the Cordoba Breast Tomosynthesis Screening Trial (CBTST):
comparison of digital breast tomosynthesis plus digital mammography to digital
mammography alone.
Eur Radiol. 2024;34:5427-5438.
PubMed
Abstract available
Association between Toll-like receptor 2 rs4696483 and rs1898830 polymorphisms
and the risk of triple-negative breast cancer.
Gene. 2024 Jul 17:148773. doi: 10.1016/j.gene.2024.148773.
PubMed
Abstract available
Development of a deep-learning model tailored for HER2 detection in breast cancer
to aid pathologists in interpreting HER2-low cases.
Histopathology. 2024 Jul 14. doi: 10.1111/his.15274.
PubMed
Abstract available
A comparative analysis of risk factor associations with interval and
screen-detected breast cancers: A large UK prospective study.
Int J Cancer. 2024;155:979-987.
PubMed
Abstract available
Genetic Counseling, Testing, and Family Communication Into Survivorship After
Diagnosis of Breast Cancer.
J Clin Oncol. 2024 Jul 15:JCO2400122. doi: 10.1200/JCO.24.00122.
PubMed
Abstract available
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early
Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial.
J Clin Oncol. 2024 Jul 17:JCO2400178. doi: 10.1200/JCO.24.00178.
PubMed
Abstract available
Risk factors for breast cancer subtypes by race and ethnicity: A scoping review.
J Natl Cancer Inst. 2024 Jul 17:djae172. doi: 10.1093.
PubMed
Abstract available
Functional ex vivo DNA fibre assay to measure replication dynamics in breast
cancer tissue.
J Pathol. 2024 Jul 18. doi: 10.1002/path.6328.
PubMed
Abstract available
Modern management of the axilla.
J Surg Oncol. 2024;130:23-28.
PubMed
Abstract available
Imaging the dense breast.
J Surg Oncol. 2024;130:29-35.
PubMed
Abstract available
Outcomes of non-angiosarcoma radiation-associated soft tissue sarcomas of the
chest.
J Surg Oncol. 2024;130:56-63.
PubMed
Abstract available
Second primary malignancies in women with breast cancer.
J Surg Oncol. 2024 Jul 19. doi: 10.1002/jso.27785.
PubMed
Abstract available
Who still needs surgical staging of the axilla for invasive breast cancer?
J Surg Oncol. 2024 Jun 21. doi: 10.1002/jso.27753.
PubMed
Abstract available
Immunohistochemical Profile of Triple-Negative Breast Cancers: SOX10 and AR Dual
Negative Tumors Have Worse Outcomes.
Mod Pathol. 2024;37:100517.
PubMed
Abstract available
Susceptibility gene mutations in germline and tumors of patients with
HER2-negative advanced breast cancer.
NPJ Breast Cancer. 2024;10:57.
PubMed
Abstract available
Differential effects of desvenlafaxine on hot flashes in women with breast cancer
taking tamoxifen: a randomized controlled trial.
NPJ Breast Cancer. 2024;10:59.
PubMed
Abstract available
Gene expression signature for predicting homologous recombination deficiency in
triple-negative breast cancer.
NPJ Breast Cancer. 2024;10:60.
PubMed
Abstract available
Artificial Intelligence-driven Prediction Revealed CFTR Associated With Therapy
Outcome Of Breast Cancer: A Feasibility Study.
Oncology. 2024 Jul 18. doi: 10.1159/000540395.
PubMed
Abstract available
Roll-out of an educational workshop to improve knowledge and self-confidence of
healthcare professionals engaged in mainstreaming of breast cancer genetics.
PLoS One. 2024;19:e0307301.
PubMed
Abstract available
Late-stage diagnosis: The driving force behind high breast cancer mortality in
Ethiopia: A systematic review and meta-analysis.
PLoS One. 2024;19:e0307283.
PubMed
Abstract available
Effects of mindfulness-based stress reduction on quality of life of breast cancer
patient: A systematic review and meta-analysis.
PLoS One. 2024;19:e0306643.
PubMed
Abstract available
Correction: Overexpression of the VRK1 kinase, which is associated with breast
cancer, induces a mesenchymal to epithelial transition in mammary epithelial
cells.
PLoS One. 2024;19:e0307693.
PubMed
Abstract available
Prevalence of BRCA mutation in breast and ovarian cancer among women in India: A
systematic review and meta-analysis protocol.
PLoS One. 2024;19:e0306612.
PubMed
Abstract available
Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially
inhibits estrogen receptor positive breast cancer cell growth.
PLoS One. 2024;19:e0306168.
PubMed
Abstract available
AKT-dependent nuclear localization of EPRS1 activates PARP1 in breast cancer
cells.
Proc Natl Acad Sci U S A. 2024;121:e2303642121.
PubMed
Abstract available
Intraindividual Comparison of Different Methods for Automated BPE Assessment at
Breast MRI: A Call for Standardization.
Radiology. 2024;312:e232304.
PubMed
Abstract available
Reporting breast cancer radiation therapy details in studies and daily practice:
Nice-to-have or a must-have?
Radiother Oncol. 2024 Jul 17:110429. doi: 10.1016/j.radonc.2024.110429.
PubMed
Quality assessment of radiotherapy in the prospective randomized SENOMAC trial.
Radiother Oncol. 2024;197:110372.
PubMed
Abstract available
Prospective phase II trial on ablative stereotactic body radiation therapy (SBRT)
for medically inoperable thoracic nodes metastases.
Radiother Oncol. 2024;197:110335.
PubMed
Abstract available
Thank you for your interest in scientific medicine.